Overview
- Anthropic announced that many parallel Claude agents scanned genomic databases and prioritized candidates that led the company to name a previously uncharacterized system Array-associated Reverse Transcriptases (ART).
- The company reports the computational search filtered hundreds of thousands of reverse transcriptase sequences down to a small set of top candidates using large-scale automated analysis.
- Human scientists in Anthropic’s BSL-1/BSL-2 lab performed initial wet-lab checks that showed the ART repeat array can express short RNAs, but those experiments did not establish the system’s biological function.
- Anthropic posted a preprint describing the workflow and results and said the finding now awaits peer review, with the CEO acknowledging related earlier observations from a Stanford team and that Claude’s role was substantial but not sole.
- Experts have called the result interesting and worthy of follow-up, and Anthropic says further experiments, community scrutiny, and collaboration are needed to test whether ART is programmable or useful for genome engineering and to assess safety.